Bone Biologics Corporation

Sümbol: BBLG

NASDAQ

1.8001

USD

Turuhind täna

  • -0.1011

    P/E suhe

  • 0.0004

    PEG suhe

  • 1.58M

    MRK Cap

  • 0.00%

    DIV tootlus

Bone Biologics Corporation (BBLG) Finantsaruanded

Diagrammil näete Bone Biologics Corporation (BBLG) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Bone Biologics Corporation fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

037.56.7
0
0
1
0.7
0.6
1.1
2.7
0
0
0
0
0
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

00.30.60
0
0
0
0
0.3
0
0.1
0
0
0
0
0
0

balance-sheet.row.inventory

0-0.3-0.60
0
0
0
0
0
0
1
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.710
0
0
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.total-current-assets

03.78.56.7
0
0
1
0.8
1
2.1
3.8
0
0
0
0
0
0

balance-sheet.row.property-plant-equipment-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

03.78.56.7
0
0
1
0.8
1
2.1
3.8
0
0
0
0
0
0

balance-sheet.row.account-payables

00.400.1
0.5
0
0.1
0.2
0.2
0.2
0.1
0
0
0
0
0
0

balance-sheet.row.short-term-debt

00-0.80
11.7
0
9
0
1.2
0
3.7
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
11.3
0
8.2
6.3
5.6
3.6
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00.52.50
1.5
0.5
0.5
0.7
1.8
2
0.1
0
0
0
0
0
0

balance-sheet.row.total-non-current-liabilities

0000
0
11.3
0
8.2
6.3
5.6
3.6
0
0
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

00.82.50.1
13.7
11.9
9.6
9.2
9.6
7.8
7.5
0
0
0
0
0
0

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-80.9-72-70.5
-68.9
-67
-63.6
-59.2
-46.9
-25.9
-12
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

083.877.977
55.1
55.1
55
50.7
38.3
20.2
8.3
0
0
0
0
0
0

balance-sheet.row.total-stockholders-equity

02.95.96.6
-13.7
-11.9
-8.6
-8.4
-8.6
-5.7
-3.7
0
0
0
0
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

03.78.56.7
0
0
1
0.8
1
2.1
3.8
0
0
0
0
0
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

02.95.96.6
-13.7
-11.9
-8.6
-8.4
-8.6
-5.7
-3.7
0
0
0
0
0
0

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0000
11.7
11.3
9
8.2
7.5
5.6
7.3
0
0
0
0
0
0

balance-sheet.row.net-debt

0-3-7.5-6.7
11.7
11.3
8
7.5
6.9
4.5
4.6
0
0
0
0
0
0

Rahavoogude aruanne

Bone Biologics Corporation finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0-8.9-1.5-1.6
-1.8
-3.4
-4.4
-7.1
-21
-13.9
-4.4
0
0
0
0
0
0

cash-flows.row.depreciation-and-amortization

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0000
0
-0.3
-0.7
0
6.1
0.5
0.9
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00.20.30.2
0.1
0
0.5
-0.6
3.5
3.7
0.3
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

00.1-0.2-0.3
0.4
0.1
0.1
0.9
0.1
0.1
-0.9
0
0
0
0
0
0

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

00.30.8-0.4
0.3
-0.1
-0.1
0
0.1
0.2
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-0.1-10
0.1
0.2
0.2
0.9
0.1
-0.1
-0.9
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0-0.9-2.20.5
0.9
0.3
0.4
3.4
4
6
1.4
0
0
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.debt-repayment

0000
-0.4
-2.3
-0.6
0
0
0
-0.9
0
0
0
0
0
0

cash-flows.row.common-stock-issued

054.46.9
0
0
4.4
0.7
2.5
0
0.5
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0001.1
0.8
4.6
0.6
2.7
4.3
2
5.8
0
0
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

054.47.9
0.4
2.3
4.4
3.4
6.8
2
5.4
0
0
0
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-4.50.96.7
0
-0.9
0.3
0.1
-0.5
-1.5
2.7
0
0
0
0
0
0

cash-flows.row.cash-at-end-of-period

037.56.7
0
0
1
0.7
0.6
1.1
2.7
0
0
0
0
0
0

cash-flows.row.cash-at-beginning-of-period

07.56.70
0
1
0.7
0.6
1.1
2.7
0
0
0
0
0
0
0

cash-flows.row.operating-cash-flow

0-9.6-3.6-1.2
-0.4
-3.3
-4.1
-3.3
-7.3
-3.5
-2.8
0
0
0
0
0
0

cash-flows.row.capital-expenditure

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.free-cash-flow

0-9.6-3.6-1.2
-0.4
-3.3
-4.1
-3.3
-7.3
-3.5
-2.8
0
0
0
0
0
0

Kasumiaruande rida

Bone Biologics Corporation tulud muutusid võrreldes eelmise perioodiga NaN%. BBLG brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

0000
0
0
0
0
0
0
0.9
0
0
0
0
0
0

income-statement-row.row.gross-profit

0000
0
0
0
0
0
0
-0.9
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0.1
2.6
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

09.43.71.1
0.8
2.4
2.8
2.6
17.8
12
3
0
0
0
0
0
0

income-statement-row.row.cost-and-expenses

09.43.71.1
0.8
2.4
2.8
2.6
17.8
12
3
0
0
0
0
0
0

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

00-2.20.8
1
-1
1.2
4.4
3.2
1.9
1.4
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

00.52.2-0.5
-1
-1
-0.4
-4.4
0
-1.9
0
0
0
0
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0.1
2.6
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

00.52.2-0.5
-1
-1
-0.4
-4.4
0
-1.9
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

00-2.20.8
1
-1
1.2
4.4
3.2
1.9
1.4
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

09.4-0.70
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-9.4-3.7-1.1
-0.8
-2.4
-2.8
-2.6
-17.8
-12
-3
0
0
0
0
0
0

income-statement-row.row.income-before-tax

0-8.9-1.5-1.6
-1.8
-3.4
-4.4
-7
-21
-13.9
-4.4
0
0
0
0
0
0

income-statement-row.row.income-tax-expense

00-2.20
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.net-income

0-8.90.7-1.6
-1.8
-3.4
-4.4
-7.1
-21
-13.9
-4.4
0
0
0
0
0
0

Korduma kippuv küsimus

Mis on Bone Biologics Corporation (BBLG) koguvara?

Bone Biologics Corporation (BBLG) koguvara on 3737763.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.000.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -17.887.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.000.

Mis on ettevõtte kogutulu?

Kogutulu on 0.000.

Mis on Bone Biologics Corporation (BBLG) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -8948731.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 0.000.

Mis on tegevuskulude arv?

Tegevuskulud on 9428303.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.